Just because something is popular doesn't mean it's right for you.
One approach that CMS has is Access model to cell and gene therapy (CGT). Under the CGT Access Model, CMS (at the federal level) will negotiate ...
That is the theme of a US Senate hearing last week. One of the people who testified was economist, USC professor Darius ...